Drugmakers turn sights on scarred lungs

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

20 Feb 2020

RT @IPFWarrior: Roche/Genentech is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibroti…

RT @IPFWarrior: Roche/Genentech is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibroti…

Roche/Genentech is spending $1.4 billion to snap up a biotech company with a first-in-class drug candidate to treat fibrotic lungs. @CurePF #PFWarriors #IPF https://t.co/z2WrAExtf8 https://t.co/iqxt44Hmuy

RT @LiminalBio: Thank you @nresearchnews @NatureBiotech for acknowledging Liminal BioSciences’ efforts in developing a potential candidate…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @TodayIpf: Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @TodayIpf: Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

RT @TodayIpf: Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

RT @TodayIpf: Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

@jessbrianphd @ImogenBrian @daniellebrian @pjbottomley

RT @TodayIpf: Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @FoxyLady0811: 🙏Hearing new #IPF #pulmonaryfibrosis drugs are in development means the world thankyou 💜 "A master regulator of fibrosis,…

This is a much welcome step. Let's keep raising awareness and keep going in the fight against this terrible disease #ipf

RT @FoxyLady0811: 🙏Hearing new #IPF #pulmonaryfibrosis drugs are in development means the world thankyou 💜 "A master regulator of fibrosis,…

Great synopsis of what is going on in the #IPF field https://t.co/E06Uzb54q0

RT @FoxyLady0811: 🙏Hearing new #IPF #pulmonaryfibrosis drugs are in development means the world thankyou 💜 "A master regulator of fibrosis,…

RT @FoxyLady0811: 🙏Hearing new #IPF #pulmonaryfibrosis drugs are in development means the world thankyou 💜 "A master regulator of fibrosis,…

🙏Hearing new #IPF #pulmonaryfibrosis drugs are in development means the world thankyou 💜 "A master regulator of fibrosis, pentraxin, is in drugmakers’ sights but drivers and mechanisms of the resulting remorseless and fatal lung disease remain unsolved" ht

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

Thank you @nresearchnews @NatureBiotech for acknowledging Liminal BioSciences’ efforts in developing a potential candidate to target this fatal Lung disease #pulmonaryfibrosis

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

I am excited to watch these unfold throughout my career. Glad to see #IPF getting the attention it deserves!

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @NatureBiotech: IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosi…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

Horrific disease with very little to nothing available currently

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

RT @KaminskiMed: It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis…

It used to be a neglected disease, considered hopeless - but now drug makers are really interested in Pulmonary Fibrosis & with a good reason! Great piece from @Cormac_Sheridan highlighting drug development in IPF in Nature Biotechnology #CureIPF #Cu

IPF is a remorseless disease, but drugmakers are stepping up efforts towards one target: a 'master regulator' of fibrosis. Read about it in Nature Biotechnology's February issue. https://t.co/e6X5dSmsdg https://t.co/dq4E4KIXIM

Go @GalapagosNV @GalapagosFrance #noveltargets #bettertreatments #RA #IPF #IBD #UC

RT @NatureBiotech: Drugmakers turn sights on scarred lungs - @Cormac_Sheridan https://t.co/8LB0i4Reld https://t.co/PkHqmxjVq8

$GLPG